Premium
Nano‐pulse stimulation induces potent immune responses, eradicating local breast cancer while reducing distant metastases
Author(s) -
Guo Siqi,
Jing Yu,
Burcus Niculina I.,
Lassiter Brittany P.,
Tanaz Royena,
Heller Richard,
Beebe Stephen J.
Publication year - 2017
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.31071
Subject(s) - immunogenic cell death , calreticulin , immune system , cancer research , tumor microenvironment , immunity , abscopal effect , cancer , immunotherapy , immunology , cancer cell , medicine , biology , microbiology and biotechnology , endoplasmic reticulum
Nano‐pulse stimulation (NPS) as a developing technology has been studied for minimally invasive, nonthermal local cancer elimination for more than a decade. Here we show that a single NPS treatment results in complete regression of the poorly immunogenic, metastatic 4T1‐Luc mouse mammary carcinoma. Impressively, spontaneous distant organ metastases were largely prevented, even in those animals with incomplete tumor regression. All tumor‐free mice were protected from secondary tumor cell challenge, demonstrating a vaccine‐like effect. NPS treatment induced antitumor immunity, long‐term memory T cells, destruction of tumor microenvironment and reversal of the massive increase of immune suppressor cells in the tumor microenvironment and blood. NPS‐treated 4T1 cells exhibited release of damage‐associated molecular patterns (DAMPs), including calreticulin, HMGB1 and ATP, and activated dendritic cells. Those findings suggest that NPS is a potent immunogenic cell death inducer that elicits antitumor immunity to prevent distant metastases in addition to local tumor eradication.